<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский онкологический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-9984</issn><issn publication-format="electronic">2412-9119</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">39968</article-id><article-id pub-id-type="doi">10.17816/onco39968</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Relationship between argyrophilic proteins of nucleolar organizer regions and antigen ki-67 with clinical and morphological parameters and survival in lung adenocarcinoma</article-title><trans-title-group xml:lang="ru"><trans-title>Взаимосвязь аргирофильных белков ядрышкообразующих районов и антигена Ki-67 с клинико-морфологическими параметрами и выживаемостью при аденокарцино-ме легкого</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kobyakov</surname><given-names>D. S</given-names></name><name xml:lang="ru"><surname>Кобяков</surname><given-names>Дмитрий Сергеевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук. зав. патологоанатомическим отд-нием</p></bio><email>dskob@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Klimachev</surname><given-names>V. V</given-names></name><name xml:lang="ru"><surname>Климачев</surname><given-names>Владимир Васильевич</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Avdalyan</surname><given-names>A. M</given-names></name><name xml:lang="ru"><surname>Авдалян</surname><given-names>Ашот Меружанович</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bobrov</surname><given-names>I. P</given-names></name><name xml:lang="ru"><surname>Бобров</surname><given-names>Игорь Петрович</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazarev</surname><given-names>A. F</given-names></name><name xml:lang="ru"><surname>Лазарев</surname><given-names>Александр Федорович</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kogalymskaya City Hospital, 628481, Kogalym, Russian Federation</institution></aff><aff><institution xml:lang="ru">Муниципальное бюджетное лечебно-профилактическое учреждение "Когалымская городская больница"</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The Altai State of Medical University of the Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО "Алтайский государственный медицинский университет"</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">Алтайский филиал ФГБУ "Российский онкологический научный центр им. Н.Н. Блохина" РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2013</year></pub-date><volume>18</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2013)</issue-title><issue-title xml:lang="ru">№3 (2013)</issue-title><fpage>21</fpage><lpage>27</lpage><history><date date-type="received" iso-8601-date="2020-07-22"><day>22</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ООО "Эко-Вектор"</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjonco.com/1028-9984/article/view/39968">https://rjonco.com/1028-9984/article/view/39968</self-uri><abstract xml:lang="en"><p>Investigated argyrophilic proteins associated with nucleolar organizer regions (Ag-NOR proteins) and Ki-67 antigen in lung adenocarcinoma. Defined tumor with low and high content of Ag-NOR proteins and proliferation index (PI) Ki-67. The content of Ag-NOR proteins had a relationship with the clinical and morphological parameters: parameters T, N, tumor size to 3 cm or more, stage of the disease. Survival of patients with lung adenocarcinoma is better in tumors with a low content of Ag-NOR proteins or PI Ki-67. High survival rate associated with low content of Ag-NOR proteins and PI Ki-67, low - with high content of Ag-NOR proteins and PI Ki-67, intermediate - with opposite values of the content of Ag-NOR proteins and PI Ki-67. Tumor size, parameter N and content of Ag-NOR proteins had an independent effect on survival. In lung adenocarcinoma with no metastasis to lymph nodes survival related to the size of the tumor, with metastases - with content of Ag-NOR proteins. Mutual study of Ag-NOR proteins and antigen Ki-67 has differential diagnostic and prognostic value in lung adenocarcinoma.</p></abstract><trans-abstract xml:lang="ru"><p>Исследованы аргирофильные белки, ассоциированные с ядрышкообразующими районами (Ag-ЯОР-белки) и антиген Ki-67 в аденокарциноме легкого. Определяли опухоли с низким и высоким содержанием Ag-ЯОР- белков и индекса метки (ИМ) Ki-67. Содержание Ag-ЯОР-белков имело связь с клинико-морфологическими параметрами: показателями Т, N, размером опухоли до 3 см и более, стадией заболевания. Выживаемость больных аденокарциномой легкого лучше при опухолях с низким содержанием Ag-ЯОР-белков или ИМ Ki-67. Высокая выживаемость связана с низким содержанием Ag-ЯОР-белков и ИМ Ki-67, низкая — с высоким содержание Ag-ЯОР-белков и ИМ Ki-67, промежуточная — с противоположными значениями содержания Ag-ЯОР-белков и ИМ Ki-67. Размер опухоли, показатель N и содержание Ag-ЯОР-белков имели независимое влияние на выживаемость больных. В аденокарциноме легкого с отсутствием метастазов в лимфатические узлы выживаемость связана с размером опухоли, при наличии метастазов — с содержанием Ag-ЯОР-белков. Взаимное исследование Ag-ЯОР-белков и антигена Ki-67 имеет дифференциально-диагностическое и прогностическое значение при аденокарциноме легкого.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Ki-67</kwd><kwd>argyrophilic proteins of nucleolar organizer regions</kwd><kwd>Ki-67</kwd><kwd>lung adenocarcinoma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аргирофильные белки ядрышкообразующих районов</kwd><kwd>аденокарцинома легкого</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Лактионов К.К., Давыдов М.И., Полоцкий Б.Е., Зборовская И.Б., Богатырев В.Н., Никуличев Л.А. и др. Прогностические и предсказывающие факторы у больных немелкоклеточным раком легкого. Практическая онкология. 2006; 7(3): 145-53.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>van Diest P.J., Brugal G., Baak J.P. Proliferation markers in tumours: interpretation and clinical value. J. Clin. Pathol. 1998; 51(10): 716-24.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Шацева Т.А., Мухина М. С. Антиген Ki-67 в оценке опухолевой пролиферации. Его структура и функция. Вопросы онкологии. 2004; 50(2): 157-64.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 2000; 182(3): 311-22.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Brown D.C., Gatter K.C. Ki-67 protein: the immaculate deception? Histopathology. 2002; 40(1): 2-11.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Jakobsen J.N., Sorensen J.B. Clinical impact of Ki-67 labeling index in non-small cell lung cancer. Lung Cancer. 2013; 79(1): 1-7.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Roussel P., Hernandez-Verdun D. Identification of AgNOR proteins, markers of proliferation related to ribosomal gene activity. Exp. Cell Res. 1994; 214(2): 465-72.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Sirri V., Roussel P., Herncndez-Verdun D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron. 2000; 31(2): 121-6.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ccnet V., Montmcsson M.P., Usson Y., Giroud F., Brugcl G. Correlation between silver-stained nucleolar organizer region area and cell cycle time. Cytometry. 2001; 43(2): 110-6.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Trere D., Pession A., Montcncro L., Chieco P., Derenzini M. AgNOR protein expression and tumor growth rate of human carcinoma xenografts growing subcutaneously in nude mice. Eur. J. Histochem. 1997; 41(Suppl. 2): 153-4.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Derenzini M., Sirri V., Trere D., Ochs R. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab. Invest. 1995; 73(4): 497-502.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ofner D., Hittmcir A., Mcrth C., Ofner D., Totsch M., Dcxenbichler G. et al. Relationship between quantity of silver-stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell lines. Pathol. Res. Pract. 1992; 188(6): 742-6.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ogurc S., Abe S., Sukoh N., Kunikcne H., Nckcjicmc I., Inoue K. et al. Correlation between nucleolar organizer regions visualized by silver staining and the growth rate of lung adenocarcinoma. Cancer. 1992; 70(1): 63-8.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Райхлин Н.Т., Букаева И.А., Смирнова Е.А., Гуревич Л.Е., Делекторская В.В., Полоцкий Б.Е. и др. Значение экспрессии ядрышковых аргирофильных белков и антигена Ki-67 в определении пролиферативной активности клеток и прогноза "малого" (Т1) рака легкого. Архив патологии. 2008; 70(3): 15-8.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ccrvclho P.E., Antoncngelo L., Berncrdi F.D., Leco L.E., Rodrigues O.R., Ccpelozzi V.L. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas. Jpn J. Clin. Oncol. 2000; 30(11): 478-86.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Mctheus R.S., Berncrdi F. Del C., Gcllo C. P., dc Silvc A. P., Rodrigues O. R., Ccpelozzi M. et al. Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas. Pathol. Res. Pract. 2004; 200(1): 13-23.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Rodrigues O.R., Antoncngelo L., Ycgi N., Mincmoto H., Schmidt Junior A.F., Ccpelozzi V.L. et al. Prognostic significance of argyrophilic nucleolar organizer region (AgNOR) in resected nonsmall cell lung cancer (NSCLC). Jpn J. Clin. Oncol. 1997; 27(5): 298-304.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Pich A., Chiusc L., Mcrgcric E. Prognostic relevance of AgNORs in tumor pathology. Micron. 2000; 31(2): 133-41.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Trcvis W.D., Brcmbillc E., Muller-Hermelink H.K., Hcrris C.C., eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ploton D., Mencger M., Jecnnesson P., Himber G., Pigeon F., Adnet J.J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem. J. 1986; 18(1): 5-14.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Aubele M., Biesterfeld S., Derenzini M., Hufncgl P., Mcrtin H., Ofner D. et al. Guidelines of AgNOR quantitation. Zbl. Pathol. 1994; 140(1): 107-8.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Derenzini M., Trere D. Standardization of interphase Ag-NOR measurement by means of an automated image analysis system using lymphocytes as an internal control. J. Pathol. 1991; 165(4): 337-42.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Cecccrelli C., Trere D., Scntini D., Tcffurelli M., Chieco P., Derenzini M. AgNORs in breast tumours. Micron 2000; 31(2): 143-9.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Giuffre G., Mormcndi F., Bcrresi V., Bordi C., Tucccri G., Bcrresi G. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool. Eur. J. Histochem. 2006; 50(1): 45-50.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Кобяков Д.С. Сравнительный анализ пролиферативной активности эпителиальных клеток аденомы и рака толстой кишки: Автореф. дис.. канд. мед. наук. Томск; 2006.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Kcneko S., Ishidc T., Sugio K., Yokoycmc H., Sugimcchi K. Nucleolar organizer regions as a prognostic indicator for stage I non-small cell lung cancer. Cancer Res. 1991; 51(15): 4008-11.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Lorenzcto M., Abboud P., Lechki C., Browcrnyj F., O’Donohue M. F., Ploton D. et al. Proliferation assessment in breast cancer: a double-staining technique for AgNOR quantification in MIB-1 positive cells especially adapted for image cytometry. Micron. 2000; 31(2): 151-9.</mixed-citation></ref></ref-list></back></article>
